Search - tctmd.com

Displaying 701 - 720 of 20307

Sort: Relevancy | Date

Presentation NY Valves 2025

Procedure Characteristics and Early Clinical Outcomes of LAAC Using a Novel Steerable Access System: A Sub-Analysis of HEAL-LAA

Presenter: Chetan Huded

June 25, 2025

Presentation NY Valves 2025

LAAC Outcomes in Patients with Prior Structural Heart Interventions

Presenter: Samir R. Kapadia

June 25, 2025

Presentation NY Valves 2025

Outcomes from the Optimize PRO Evolut FX System Addendum Study: 30-Day and 1-Year Results

Presenter: Hemal Gada

June 25, 2025

Presentation NY Valves 2025

National Trends in Aortic Valve Replacement in Patients 65 Years and Younger

Presenter: Vikrant Jagadeesan

June 25, 2025

Presentation NY Valves 2025

Death on Waiting List for Transcatheter Aortic Valve Implantation: Current Incidence, Clinical Characteristics and Predictive Factors

Presenter: Hugo Poinsignon

June 25, 2025

Presentation NY Valves 2025

Correction of Doppler Gradients for LVOT Flow and Pressure Recovery Following Balloon-Expandable TAVR

Presenter: Muhammad Suleman

June 25, 2025

Presentation NY Valves 2025

Late Health Status Outcomes with Patient-Prosthesis Mismatch After AVR in the PARTNER Trials

Presenter: Yasser M. Sammour

June 25, 2025

Presentation NY Valves 2025

First in Human Study of the Microtech Novel Implantable Pressor Sensor in LVAD Patients

Presenter: Nir Uriel

June 25, 2025

Presentation NY Valves 2025

Right Heart Remodeling Following TTVR With the VDyne System: Results From the VISTA EFS Program

Presenter: Nadira Hamid

June 25, 2025

Presentation NY Valves 2025

30-Day Outcomes of the Lux-Plus TTVR System in Large Tricuspid Annuli in the TRINITY Trial

Presenter: Thomas Elie Modine

June 25, 2025

Presentation NY Valves 2025

Early Feasibility Experience of Posterior Leaflet Restoration to Reduce Secondary MR Using the MRace Implant (EXPLORE MR)

Presenter: Fabio Sandoli de Brito

June 25, 2025

Presentation NY Valves 2025

SIEGEL TAVR: FIH 1 year & US Early Feasibility 30 Day Results

Presenter: Pradeep K. Yadav

June 25, 2025

Presentation NY Valves 2025

A Contemporary View on Pathophysiology and Clinical Significance of LVOT in HCM

Presenter: Anjali Owens

June 25, 2025

Presentation NY Valves 2025

Key Take-Aways

Presenter: Rishi Puri

June 25, 2025

Presentation NY Valves 2025

Heart Team Discussion: Lifetime Management Considerations

Presenter: Sachin S. Goel

June 25, 2025

Presentation NY Valves 2025

Heart Team Discussion: Importance of Preserving Coronary Access after TAVI

Presenter: Laura Flannery

June 25, 2025

Presentation NY Valves 2025

Latest Clinical Insights: Bridging Evidence and Practice

Presenter: Samir R. Kapadia

June 25, 2025

Presentation NY Valves 2025

Navitor Vision Valve Case Presentation

Presenter: Mark J. Ricciardi

June 25, 2025

Presentation NY Valves 2025

Heart Team Discussion: Optimal Implantation Technique

Presenter: Saurabh Sanon

June 25, 2025

Presentation NY Valves 2025

Heart Team Discussion: Importance of PPM

Presenter: Rishi Puri

June 25, 2025

Advertisement

Procedure Characteristics and Early Clinical Outcomes of LAAC Using a Novel Steerable Access System: A Sub-Analysis of HEAL-LAA

LAAC Outcomes in Patients with Prior Structural Heart Interventions

Outcomes from the Optimize PRO Evolut FX System Addendum Study: 30-Day and 1-Year Results

National Trends in Aortic Valve Replacement in Patients 65 Years and Younger

Death on Waiting List for Transcatheter Aortic Valve Implantation: Current Incidence, Clinical Characteristics and Predictive Factors

Correction of Doppler Gradients for LVOT Flow and Pressure Recovery Following Balloon-Expandable TAVR

Late Health Status Outcomes with Patient-Prosthesis Mismatch After AVR in the PARTNER Trials

First in Human Study of the Microtech Novel Implantable Pressor Sensor in LVAD Patients

Right Heart Remodeling Following TTVR With the VDyne System: Results From the VISTA EFS Program

30-Day Outcomes of the Lux-Plus TTVR System in Large Tricuspid Annuli in the TRINITY Trial

Early Feasibility Experience of Posterior Leaflet Restoration to Reduce Secondary MR Using the MRace Implant (EXPLORE MR)

SIEGEL TAVR: FIH 1 year & US Early Feasibility 30 Day Results

A Contemporary View on Pathophysiology and Clinical Significance of LVOT in HCM

Key Take-Aways

Heart Team Discussion: Lifetime Management Considerations

Heart Team Discussion: Importance of Preserving Coronary Access after TAVI

Latest Clinical Insights: Bridging Evidence and Practice

Navitor Vision Valve Case Presentation

Heart Team Discussion: Optimal Implantation Technique

Heart Team Discussion: Importance of PPM

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content